Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Tax Provisions (2019 - 2025)

CorMedix has reported Tax Provisions over the past 7 years, most recently at $42.4 million for Q4 2025.

  • Quarterly results put Tax Provisions at $42.4 million for Q4 2025, up 18446315.22% from a year ago — trailing twelve months through Dec 2025 was -$13.0 million (down 834.71% YoY), and the annual figure for FY2025 was -$13.0 million, down 834.7%.
  • Tax Provisions reached $42.4 million in Q4 2025 per CRMD's latest filing, up from -$56.0 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $42.4 million in Q4 2025 and bottomed at -$56.0 million in Q3 2025.
  • Median Tax Provisions over the past 4 years was -$292923.5 (2022), compared with a mean of -$1.8 million.
  • The largest annual shift saw Tax Provisions crashed 71.16% in 2021 before it soared 18446315.22% in 2025.
  • Over 4 years, Tax Provisions stood at $1.9 million in 2021, then tumbled by 131.21% to -$585617.0 in 2022, then surged by 99.96% to -$230.0 in 2024, then skyrocketed by 18446315.22% to $42.4 million in 2025.
  • Business Quant data shows Tax Provisions for CRMD at $42.4 million in Q4 2025, -$56.0 million in Q3 2025, and $521507.0 in Q2 2025.